Stockreport

Tectonic Therapeutic Initiates Phase 1B Study for TX45 in Group 2 Pulmonary Hypertension in Patients with Preserved Ejection Fraction Heart Failure [Yahoo! Finance]

AVROBIO, Inc.  (AVRO) 
Last avrobio, inc. earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.avrobio.com/investor-relations
PDF TX45 clinical program advancing on track based on promising initial Phase 1A data; confirmatory Phase 1A data expected mid-2024 and topline Phase 1B data expected in 20 [Read more]